Kjaerulff
Lene S. Kjaerulff, Skaevinge DK
Patent application number | Description | Published |
---|---|---|
20120322848 | LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER - The present disclosure concerns LNA oligonucleotides having a (sub)sequence of the general formula 5′-( | 12-20-2012 |
Soeren Kjaerulff, Vanlose DK
Patent application number | Description | Published |
---|---|---|
20110287516 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, comprising mutations in two, three, four, five or six regions/positions. The variants have increased stability at high temperatures (relative to the parent). The invention also relates to a DNA construct comprising a DNA sequence encoding an alpha-amylase variant of the invention, a recombinant expression vector which carries a DNA construct of the invention, a cell which is transformed with a DNA construct of the invention, the use of an alpha-amylase variant of the invention for washing and/or dishwashing, textile desizing, starch liquefaction, a detergent additive comprising an alpha-amylase variant of the invention, a manual or automatic dishwashing detergent composition comprising an alpha-amylase variant of the invention, a method for generating a variant of a parent Termamyl-like alpha-amylase, which variant exhibits increased. | 11-24-2011 |
Soeren Kjaerulff, Holte DK
Patent application number | Description | Published |
---|---|---|
20100016230 | Treatment Of Inflammatory Bowel Diseases With Mammal Beta Defensins - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 01-21-2010 |
20100016231 | Treatment Of Rheumatoid Arthritis With Mammal Beta Defensins - The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins. | 01-21-2010 |
20100016232 | Treatment Of Inflammatory Diseases With Mammal Beta Defensins - The present invention relates to suppression of TNF-alpha activity with mammal beta defensins, which has utility in the treatment of pathological conditions associated with tumor necrosis factor alpha. | 01-21-2010 |
20110251139 | TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH MAMMAL BETA DEFENSINS - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 10-13-2011 |
20120309678 | Treatment of Inflammatory Bowel Diseases With Mammal Beta Defensins - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 12-06-2012 |
20120309686 | Treatment of Rheumatoid Arthritis With Mammal Beta Defensins - The present invention relates to treatment of rheumatoid arthritis with mammal beta defensins. | 12-06-2012 |
20140135258 | Treatment of Inflammatory Bowel Diseases with Mammal Beta Defensins - The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | 05-15-2014 |
Sóeren Kjaerulff, Vanlose DK
Patent application number | Description | Published |
---|---|---|
20120252095 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, comprising mutations in two, three, four, five or six regions/positions. The variants have increased stability at high temperatures (relative to the parent). The invention also relates to a DNA construct comprising a DNA sequence encoding an alpha-amylase variant of the invention, a recombinant expression vector which carries a DNA construct of the invention, a cell which is transformed with a DNA construct of the invention, the use of an alpha-amylase variant of the invention for washing and/or dishwashing, textile desizing, starch liquefaction, a detergent additive comprising an alpha-amylase variant of the invention, a manual or automatic dishwashing detergent composition comprising an alpha-amylase variant of the invention, a method for generating a variant of a parent Termamyl-like alpha-amylase, which variant exhibits increased. | 10-04-2012 |
Soren Kjaerulff, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20150099284 | Alpha-Amylase Mutants with Altered Properties - The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca | 04-09-2015 |
Soren Kjaerulff, Hillerod DK
Patent application number | Description | Published |
---|---|---|
20080227154 | Protein Expression - Disclosed is chimeric polynucleotides adopted for providing high-yield expression and secretion of recombinant polypeptides. The chimeric polynucleotide of the invention includes a functional secretion signal peptide derived from | 09-18-2008 |
20090098592 | METHOD - A method is described for releasing a soluble or membrane associated intracellular protein of interest (POI) comprising the steps of: providing a cell comprising a soluble or membrane associated intracellular POI; contacting the cell with a membrane extracting composition; and causing the POI to be released from the cell under conditions sufficient for the specific release of the POI and in a soluble form. | 04-16-2009 |
20120083426 | METHOD - A method is described for releasing a soluble or membrane associated intracellular protein of interest (POI) comprising the steps of: providing a cell comprising a soluble or membrane associated intracellular POI; contacting the cell with a membrane extracting composition; and causing the POI to be released from the cell under conditions sufficient for the specific release of the POI and in a soluble form. | 04-05-2012 |
Soren Kjaerulff, Vanloese DK
Patent application number | Description | Published |
---|---|---|
20140017715 | Alpha-amylase Mutants - The invention relates to a variant of a parent Termamyl-like α-amylase, which exhibits an alteration in at least one of the following properties relative to said parent α-amylase: i) improved pH stability at a pH from 8 to 10.5; and/or ii) improved Ca | 01-16-2014 |
20140248685 | Alpha-amylase Mutants - The invention relates to a variant of a parent Termamyl-like α-amylase, which exhibits an alteration in at least one of the following properties relative to said parent α-amylase: i) improved pH stability at a pH from 8 to 10.5; and/or ii) improved Ca | 09-04-2014 |
Søren Kjaerulff, Hillerød DK
Patent application number | Description | Published |
---|---|---|
20150053872 | APPARATUS AND METHODS FOR ANALYSING FLUORESCENT PARTICLES - According to an embodiment of the invention, an apparatus to detect fluorescence from a sample is disclosed. The apparatus comprises a sample plane onto which the sample is arranged, an excitation light unit including at least a light source to illuminate the sample, and a detection unit comprising at least a detector having at least 100,000 active detection elements to detect a fluorescence signal from the sample. | 02-26-2015 |
Søren Kjaerulff, Vanlose DK
Patent application number | Description | Published |
---|---|---|
20110086132 | TRANSGENIC PLANT EXPRESSING MALTOGENIC ALPHA-AMYLASE - A transgenic plant cell expressing a maltogenic amylase (such as Novamyl®) or a beta-amylase; a transgenic plant regenerated from said cell; seeds generated from such plant where said seeds comprise a maltogenic amylase or a beta-amylase and the use of said seeds, optionally in ground form, for catalyzing an industrial process, such as e.g. in baking. The maltogenic amylase providing an anti staling effect in bread produced from the seeds in question. | 04-14-2011 |
20120122754 | Alpha-Amylase Variants - The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase. | 05-17-2012 |